NEW YORK (GenomeWeb) – Exact Sciences reported on Sunday that it expects fourth quarter revenues of $34.9 million to $35.4 million, and FY 2016 revenues of $99.0 million to $99.5 million.

The firm's preliminary revenues soundly beat the average Wall Street estimate of $30.2 million for Q4 and $94.2 million for 2016.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.